SCHEMBL15328348

SCHEMBL15328348

COc1cc(N2CCOCC2)cc(F)c1C(=O)NCc1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.48
CFTR P13569 1/20 0.46
SIK1 P57059 2/20 0.46
SIK2 Q9H0K1 2/20 0.46
SIK3 Q9Y2K2 2/20 0.46
HDAC3 O15379 2/20 0.46
HDAC1 Q13547 2/20 0.46
HDAC2 Q92769 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
TUBB4A P04350 1/20 0.46
TUBB P07437 1/20 0.46
TUBA3C P0DPH7 1/20 0.46
TUBA1B P68363 1/20 0.46
TUBA4A P68366 1/20 0.46
TUBB4B P68371 1/20 0.46
TUBB3 Q13509 1/20 0.46
TUBB2A Q13885 1/20 0.46
TUBB8 Q3ZCM7 1/20 0.46
TUBA3E Q6PEY2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15328358 0.89 MEN1 (0.48) LMNACFTRSIK1SIK2SIK3
SCHEMBL15328406 0.87 CFTR (0.45) LMNACFTRSIK1SIK2SIK3
SCHEMBL15328467 0.86 ERCC1 (0.47) LMNAHDAC1HDAC6MAPK1MAPT
SCHEMBL15524988 0.85 MAPK8 (0.40) LMNASIK1SIK2SIK3HCRTR2
SCHEMBL15328281 0.84 S1PR3 (0.48) LMNAL3MBTL1MAPK1MAPTPPARG
SCHEMBL15328232 0.83 PPARG (0.46) LMNAMAPTPPARGMEN1KMT2A
SCHEMBL15328957 0.83 LMNA (0.51) LMNACFTRSIK1SIK2SIK3
SCHEMBL15328286 0.80 RXFP1 (0.48) LMNAMAPTMEN1ALDH1A1KMT2A
SCHEMBL15328143 0.80 MEN1 (0.47) LMNAL3MBTL1PPARGMEN1KMT2A
SCHEMBL15328253 0.78 KMT2A (0.48) HDAC8MAPTKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108936-B2 Substituted 4-aminobenzamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2015-08-18 US disclosed
EP-2844645-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2015-03-11 EP disclosed
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2013-10-24 US disclosed
WO-2013156155-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2013-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS KCNJ2, KCNQ2, KCNQ1 LMNA 1359/4885CFTR 358/4885SIK1 3305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.